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All patients were critically sick, needed admission in
intensive care unit for inotropic or ventilatory support.
All underwent successful percutaneous balloon angio-
plasty with no major complications. The clinical condition
and left ventricular function improved leading to discon-
tinuation of prostaglandin and weaning from inotrope
and ventilator support. Seven patients underwent elec-
tive surgical repair after a mean time of one month, three
needed re-dilation and five continued without any fur-
ther intervention.
Conclusions: Surgical repair for native neonatal and
infantile coarctation is a preferred choice of treatment
but it can be challenging in critically sick patients.
However, balloon dilation remains a safe and effective
temporary palliation for the critically sick patients.
Despite of high incidence of restenosis, some patients
do not need for mid-term further intervention.
http://dx.doi:10.1016/j.jsha.2015.05.193
13. Immediate Effect of percutaneous transvenous
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cal delay and left atrial mechanical functions in
patients with rheumatic mitral stenosis
Nisar A. Tramboo, Jahangir Rashid Beig, Hilal A.
Rather, Imran Hafiz
Background: Rheumatic mitral stenosis (MS) is associated
with prolonged inter and intra-atrial electromechanical
delays and impaired left atrial (LA) mechanical functions,
which are considered to be markers of atrial fibrillation
(AF) risk. This study was conducted to assess the imme-
diate effect of successful percutaneous transvenous
mitral commissurotomy (PTMC) on these parameters.
Methods: This observational study included 25 patients
with symptomatic, severe MS (aged 34.1 ± 7.1 years, with
mean mitral valve area (MVA) of 0.74 ± 0.13 cm2), in
normal sinus rhythm, who underwent successful PTMC
at our hospital. Inter-atrial (AEMD), left intra-atrial
(L-IAEMD) and right intra-atrial (R-IAEMD) electrome-
chanical delays were measured on tissue Doppler imag-
ing. Phasic LA volumes (Vmax: maximal LA volume, Vmin:
minimal LA volume and Vp: LA volume at P-wave onset)
were measured by modified Simpson’s method.
Parameters of LA reservoir function i.e. LA total emptying
fraction (LATEF) and LA expansion index (LAEI); conduit
function i.e. LA passive emptying fraction (LAPEF); and
pump function i.e. LA active emptying fraction (LAAEF)
were calculated from the phasic LA volumes. PTMC was
performed using the standard Inoue Balloon technique.
All these parameterswere evaluated and compared before
and 24–48 h after PTMC.
Results: Successful PTMC led to significant reduction in
AEMD (p < 0.001), L-IAEMD (p < 0.001), R-IAEMD (p <
0.001), Vmax (p < 0.001), Vmin (p < 0.001) and Vp (p < 0.001).
There were significant increments in LATEF (p = 0.001),
LAEI (p = 0.002) and LAPEF (p = 0.05), while there was no
significant change in LAAEF (p = 0.127) after PTMC.
Conclusions: Successful PTMC has a favorable early
impact on left atrial mechanical functions and other novel
parameters of atrial electromechanical remodeling in MS
patients. Large scale prospective studies are required to
confirm whether improvement in these markers trans-
lates into reduced long term AF risk in these patients.
http://dx.doi:10.1016/j.jsha.2015.05.194
14. Prince Sultan Cardiac Center experience on
mitral clip (What is new?)
Hatim Khieralla Osman, Sondos Ahmad
Samargandy
Demographics:
 Total number of patients: 33
 22 males (63.6%) + 12 females (36.6%)
 Age (min 43 & max 92 with mean 66.82  SD 12.5)
 Etiology:
 Functional ischemic = 13 (39.3%)
 Degenerative = 4 (12.12)
 Flail AML/ISCHEMIC = 1 (3%)
 Functional non ischemic = 15 (45.45%)
Summary:
1. EF-have increased after the intervention in all periods
of monitoring time, however it was only statistically
significant at 6th month using t-test with
p-value = 0.024. Moreover, assuming that the distribu-
tion is not normal, using Wilcoxon Signed Ranked
Test, out of 10 people in sixth month, 5 have positively
increased EF and the other 5 remains the same with a
z-value = 2.121, p-value = 0.034.
2. PASP –Due to the attrition rate, only comparisons up to
sixth months can be fairly interpreted. The results
shows that on the sixth month monitoring, PASP all
decreased at a certain level but only statistically signifi-
cant at the first day using Paired t-test, with
p-value = 0.015. Again assuming that the distribution
is not Gaussian, Wilcoxon Signed Ranked test shows
that out of 22 patients, 14 (63.64%) had decreased
PASP, 4 (18.18%) have increased and 4 (18.18%) remains
the same with z-value = 2.379, p-value = 0.017
3. MR improvement:
 No change (remained sever) = 6 patients (2 degenar-
ative, 3 functional, 1 ischemic) 18.18%
 One degree improvement (severe to mod) = 18
(54.5%)
 Two degrees improvement (sever to mild) = 5
(15.15%)
 Three degrees (sever to non/residual) = 1(3%)
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